Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alder biopharmaceuticals
amgen
bio
biology
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
clinical trials
crispr
david rind
detroit blog main
detroit top stories
drama
editas medicine
eli lilly
enzymes
episodic migraine
eptinezumab
erenumab
fda
food and drug administration
fremanezumab
galcanezumab
genetics
indiana blog main
indiana top stories
institute for clinical and economic review
jennifer doudna
life sciences
migraine research foundation
migraines
national
national blog main
national top stories
new york blog main
new york top stories
What
head
2
×
starts
2
×
amgen
approval
argument
arguments
begin
berkeley’s
candidates
cas
charpentier
class
colleague
court
crispr
date
december
developed
doudna
drug
editing
emmanuelle
fda
feng
gene
gets
institute
jennifer
judges
max
medicines
migraine
mit’s
month
new
nod
office
oral
owns
pain
Language
Current search:
starts
×
head
×
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@techcrunch.com
7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month
